Neurocrine Biosciences, Inc. (NBIX)
139.90
+0.34
(+0.24%)
USD |
NASDAQ |
Feb 10, 12:45
Neurocrine Biosciences EPS Diluted (Quarterly) : 2.044 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Bio-Rad Laboratories, Inc. | -12.70 |
| Edwards Lifesciences Corp. | 0.5004 |
| Masimo Corp. | -1.859 |
| Marker Therapeutics, Inc. | -0.1193 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 209.50M |
| Revenue (Quarterly) | 794.90M |
| Total Expenses (Quarterly) | 585.40M |
| Enterprise Value | 13.28B |
| Gross Profit Margin (Quarterly) | 98.24% |
| Profit Margin (Quarterly) | 26.36% |
| Earnings Yield | 2.99% |
| Operating Earnings Yield | 3.87% |
| Normalized Earnings Yield | 3.052 |